FMC = RISK: Vote the GOLD Proxy Card
27. Juni 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 27, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed a letter to stockholders advising them to protect the value of their investment in VIVUS...
VIVUS Announces SPEDRA (avanafil) Approval in Europe
26. Juni 2013 13:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 26, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today announced that the European Commission (EC) has adopted the implementing decision granting...
VIVUS Comments on Sam Colin's Questionable Claims
25. Juni 2013 07:00 ET
|
VIVUS, Inc.
Urges Stockholders Not to be Misled by Sam Colin and His Hedge Fund, First Manhattan Co.
Believes FMC's Recent Letter to VIVUS Stockholders Contains Several
Highly Questionable Claims
Protect...
VIVUS Announces ADA Scientific Presentations
21. Juni 2013 07:30 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 21, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS Announces AANP Scientific Presentations
21. Juni 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 21, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS Announces Study Results Showing STENDRA (Avanafil) is Effective for Sexual Activity Within 15 Minutes in Men With Erectile Dysfunction (ED)
19. Juni 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 19, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced positive results from a multicenter, placebo-controlled study, TA-501, designed to assess the...
VIVUS Posts Investor Presentation
19. Juni 2013 06:00 ET
|
VIVUS, Inc.
Urges Stockholders Not to be Misled by FMC's Distracting Proxy Campaign
Vote the GOLD Proxy Card Today and Support VIVUS's Highly Qualified Directors
MOUNTAIN VIEW, Calif., June 19, 2013 (GLOBE...
New Review Article Discusses Complications-Centric Approach to Obesity Medical Management With Qsymia
17. Juni 2013 07:30 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that a review article has been published online in Expert Opinion on Drug Safety examining the...
VIVUS Urges Stockholders to Support the Board of Directors and Management Team at This Critical Time
17. Juni 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed a letter to stockholders advising them to protect the value of their investment in VIVUS...
VIVUS Announces Scientific Presentations
15. Juni 2013 14:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 15, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...